| Literature DB >> 18718127 |
Sung Ho Chang1, Eun Jung Jung, Dong Gyun Lim, Baatartsogt Oyungerel, Kwan Il Lim, Erk Her, Wahn Soo Choi, Myung Ha Jun, Kang Duk Choi, Duck Jong Han, Song Cheol Kim.
Abstract
This study examined whether an extract of Cudrania tricuspidata shows anti-proliferative effects in anti-CD3/CD28-mediated spleen and CD4+CD25- T cells and decreases the production of the proinflammatory cytokines interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) in anti-CD3/CD28-mediated CD4+CD25- T cells. The proliferation of anti-CD3/CD28-mediated spleen cells and CD4+CD25- T cells was effectively suppressed by C. tricuspidata. This extract, however, did not show cytotoxicity in spleen cells under conditions where the antigen was not stimulated using CCK-8 analysis. C. tricuspidata also decreased the production of the pro-inflammatory cytokines IL-2 and IFN-gamma by selective inhibition of this extract on proliferating cells in anti-CD3/CD28-mediated CD4+CD25- T cells. These results suggest that C. tricuspidata may be useful in the treatment of autoimmune diseases and organ transplantation through the inhibitory action of T cells in inflammation.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18718127 DOI: 10.1211/jpp.60.9.0015
Source DB: PubMed Journal: J Pharm Pharmacol ISSN: 0022-3573 Impact factor: 3.765